Cambridge Investment Research Advisors’s Editas Medicine EDIT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $389K | Buy |
176,604
+90,888
| +106% | +$200K | ﹤0.01% | 2772 |
|
|
2025
Q1 | $99K | Sell |
85,716
-631
| -0.7% | -$729 | ﹤0.01% | 3351 |
|
|
2024
Q4 | $110K | Buy |
86,347
+11,926
| +16% | +$15.2K | ﹤0.01% | 3317 |
|
|
2024
Q3 | $254K | Buy |
74,421
+474
| +0.6% | +$1.62K | ﹤0.01% | 2954 |
|
|
2024
Q2 | $345K | Sell |
73,947
-3,335
| -4% | -$15.6K | ﹤0.01% | 2590 |
|
|
2024
Q1 | $573K | Sell |
77,282
-2,367
| -3% | -$17.6K | ﹤0.01% | 2166 |
|
|
2023
Q4 | $807K | Buy |
79,649
+4,204
| +6% | +$42.6K | ﹤0.01% | 1801 |
|
|
2023
Q3 | $588K | Buy |
75,445
+2,453
| +3% | +$19.1K | ﹤0.01% | 1949 |
|
|
2023
Q2 | $601K | Buy |
72,992
+8,243
| +13% | +$67.9K | ﹤0.01% | 1990 |
|
|
2023
Q1 | $469K | Buy |
64,749
+722
| +1% | +$5.23K | ﹤0.01% | 2133 |
|
|
2022
Q4 | $568K | Sell |
64,027
-2,444
| -4% | -$21.7K | ﹤0.01% | 1915 |
|
|
2022
Q3 | $814K | Buy |
66,471
+1,159
| +2% | +$14.2K | ﹤0.01% | 1614 |
|
|
2022
Q2 | $773K | Buy |
65,312
+752
| +1% | +$8.9K | ﹤0.01% | 1655 |
|
|
2022
Q1 | $1.23M | Sell |
64,560
-1,316
| -2% | -$25K | 0.01% | 1432 |
|
|
2021
Q4 | $1.75M | Sell |
65,876
-111,405
| -63% | -$2.96M | 0.01% | 1223 |
|
|
2021
Q3 | $7.28M | Buy |
177,281
+82,042
| +86% | +$3.37M | 0.04% | 460 |
|
|
2021
Q2 | $5.39M | Buy |
95,239
+401
| +0.4% | +$22.7K | 0.03% | 582 |
|
|
2021
Q1 | $3.98M | Sell |
94,838
-6,586
| -6% | -$277K | 0.02% | 666 |
|
|
2020
Q4 | $7.11M | Buy |
101,424
+91,908
| +966% | +$6.44M | 0.04% | 398 |
|
|
2020
Q3 | $267K | Sell |
9,516
-5,091
| -35% | -$143K | ﹤0.01% | 2027 |
|
|
2020
Q2 | $432K | Buy |
14,607
+1,887
| +15% | +$55.8K | ﹤0.01% | 1642 |
|
|
2020
Q1 | $252K | Buy |
12,720
+5,012
| +65% | +$99.3K | ﹤0.01% | 1779 |
|
|
2019
Q4 | $228K | Buy |
+7,708
| New | +$228K | ﹤0.01% | 2113 |
|
|
2018
Q3 | – | Sell |
-5,594
| Closed | -$200K | – | 2255 |
|
|
2018
Q2 | $200K | Sell |
5,594
-646
| -10% | -$23.1K | ﹤0.01% | 2016 |
|
|
2018
Q1 | $207K | Buy |
+6,240
| New | +$207K | ﹤0.01% | 1941 |
|